[Leukemia in patients with breast carcinoma after adjuvant chemotherapy and/or postoperative radiotherapy].
Sack
H
H
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001943:Breast Neoplasms / Q000150:complications / Q000532:radiotherapy / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000009:adverse effects; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects; D006801:Humans; D007938:Leukemia / Q000139:chemically induced / Q000453:epidemiology* / Q000209:etiology; D007953:Leukemia, Radiation-Induced / Q000453:epidemiology / Q000209:etiology; D008350:Manitoba / Q000453:epidemiology; D008558:Melphalan / Q000009:adverse effects; D008727:Methotrexate / Q000009:adverse effects; D008875:Middle Aged; D015999:Multivariate Analysis; D016609:Neoplasms, Second Primary / Q000453:epidemiology* / Q000209:etiology; D011182:Postoperative Care; D018714:Radiotherapy, Adjuvant; D013997:Time Factors
D003520:Cyclophosphamide; D008558:Melphalan; D005472:Fluorouracil; D008727:Methotrexate
Leukämie bei Patientinnen mit Mammakarzinom nach adjuvanter Chemo- und/oder postoperativer Strahlentherapie.